PHC (PARIS HEPATOLOGY CONFERENCE) 2018 – Slides
-
08:30 - 08:45
Introduction: Liver Diseases: a large scale sceening is needed
-
Patrick MARCELLIN (France)
Download
-
08:45 - 09:50
HEPATITIS C - SESSION 1
Chairs :
Michael MANNS (Germany) Tarik ASSELAH (France)
-
08:45 - 09:00
Treatment of HCV: 100 % cure ?
- Tarik ASSELAH (France)
Download
-
09:00 - 09:15
Difficult to treat patients
- Stefan ZEUZEM (Germany)
Download
-
09:15 - 09:30
Results in real life
- Christophe HEZODE (France)
Download
- 09:30 - 09:50 Round table discussion
- 09:50 - 10:10 CLINICAL CASE
-
Management of a patient with HCV related vasculitis
- Eugene SCHIFF (USA)
Download
- 10:10 - 10:40 Coffee Break
-
10:40 - 11:45
HEPATITIS C - SESSION 2
Chairs :
Mitchell SHIFFMAN (USA) Marc BOURLIERE (France)
-
10:40 - 10:55
Cost benefit of treatment in F1 patients
- Graham FOSTER (UK)
Download
-
10:55 - 11:10
Special populations
- Stanislas POL (France)
Download
-
11:10 - 11:25
The next wave of HCV : The epidemic of intravenous drug use
- Mitchell SHIFFMAN (USA)
Download
- 11:25 - 11:45 Round table discussion
-
11:45 - 12:30
State of the art LECTURE and award
Chairman:
Patrick MARCELLIN (France)
-
12:30 - 14:30 Luncheon workshops 1-How to improve access to treatment in HCV patients
Chairs: Graham FOSTER (UK) Gamal ESMAT (Egypt)
Download
2-Optimal treatment strategy in HCV patients
Chairs: Geoffrey DUSHEIKO (UK) Adrian GADANO (Argentina)
3-Treatment strategy in patients with HIV-HCV co-infection
Chairs: Mitchell SHIFFMAN (USA) Stanislas POL (France)
4-Delta hepatitis: current epidemiology and optimized therapy
Chairs: Mario RIZZETTO (Italy)
Download
Christian TREPO (France)
5-Optimal management of auto-immune hepatitis
Chairs: Michael MANNS (Germany) Peter GALLE (Germany)
6-Treatment of HCC in real life
Chairs: Peter FERENCI (Austria) Olivier ROSMORDUC (France)
7-Optimisation de la prise en charge d’un patient avec ascite (French speaking lunch workshop)
Chairs: Philippe MATHURIN (France) Christophe MORENO (Belgium)
Speakers:
Claire FRANCOZ (France)
Mustapha BENAZZOUZ (Morocco)
Download
Jean-Charles DUCLOS VALLEE (France)
-
14:30 - 15:45
NASH SESSION
Chairs :
Lawrence SERFATY (France) Arun SANYAL (USA)
-
14:30 - 14:45
Worldwide Epidemiology of NAFLD
- Stefano BELLENTANI (Italy)
Download
-
14:45 - 15:00
Prognosis of NASH
- Jean François DUFOUR (Switzerland)
Download
-
15:00 - 15:15
Management of a patient with NASH in real life
- Lawrence SERFATY (France)
Download
-
15:15 - 15:30
Future therapies in NASH
- Arun SANYAL (USA)
Download
- 15:30 - 15:45 Round table discussion
-
15:45 - 16:15
CONTROVERSY: diagnosis of NASH
Chairs :
Lawrence SERFATY (France) Arun SANYAL (USA)
-
15:45
Liver Biopsy
- Pierre BEDOSSA (France)
Download
-
16:00
Indirect markers
- Laurent CASTERA (France)
Download
- 16:15 - 16:35 Coffee break
- 16:35 - 18:10 Around the World Table: Access to HCV therapy
-
Introduction
- Patrick MARCELLIN (France)
Download
-
Western countries
- Speakers:
Michael FRIED (USA)
Download
Maria BUTI (Spain)
Download
Massimo COLOMBO (Italy)
Download
Graham FOSTER (UK)
Victor DE LEDINGHEN (France)
Download
Thomas BERG (Germany)
Download
-
Other countries
- Speakers:
Mustapha BENAZZOUZ (Morocco)
Download
Robert FLISIAK (Poland)
Vasily ISAKOV (Russia)
Adriana POPESCU (Romania)
Raymundo PARANA (Brazil)
Gamal ESMAT (Egypt)
Download
-
Special communication
- How to manage liver patients during war - Speaker:
Nabil ANTAKI (Syria)
Download
-
18:10
Take home messages
-
Marc BOURLIERE (France)
Download
- 18:20 Conclusion - Patrick MARCELLIN (France)
- 18:40 - 20:00 Industry satellite symposium
- 07:30 - 08:30 Industry satellite symposium
-
08:30 - 08:45
Introduction
-
Patrick MARCELLIN (France)
Download
-
08:45 - 09:50
HEPATITIS B - SESSION 1
Chairs :
Jidong JIA (China) Georgios PAPATHEODORIDIS (Greece)
-
08:45 - 09:00
Who and when to treat ?
- Georgios PAPATHEODORIDIS (Greece)
Download
-
09:00 - 09:15
Is there still a role for interferon ?
- Pietro LAMPERTICO (Italy)
Download
-
09:15 - 09:30
Long term safety and efficacy of NUCs
- Maria BUTI (Spain)
Download
- 09:30 - 09:50 Round table discussion
-
09:50 - 10:20
CONTROVERSY: To stop or not to stop NUCs ?
Chairman:
Georgios PAPATHEODORIDIS (Greece)
- YES - Thomas BERG (Germany)
- NO - Adrian GADANO (Argentina)
- 10:20 - 10:40 Coffee Break
-
10:40 - 11:40
HEPATITIS B - SESSION 2
Chairs :
Rafael ESTEBAN (Spain) Shiv SARIN (India)
- 10:40 - 10:55 New anti-HBV therapies - Raymond SCHINAZI (USA)
-
10:55 - 11:10
Delta hepatitis revisited
- Mario RIZZETTO (Italy)
Download
-
11:10 - 11:25
How to improve access to therapy for HBV patients?
- Fabien ZOULIM (France)
Download
- 11:25 - 11:40 Round table discussion
-
11:40 - 12:10
How to control HBV in high endemic regions?
Chairman:
Patrick MARCELLIN (France)
-
Asia
- Jidong JIA (China)
Download
-
Sub-saharian African
- Lamine DIOUF (Senegal)
Download
-
12:10 - 12:30
State of the art LECTURE
Chairman:
Patrick MARCELLIN (France)
-
The revolution of imagery in liver diseases
- Valérie VILGRAIN (France)
Download
-
12:30 - 14:30 Luncheon Workshops 1-How to diagnose NASH?
Chairs: Arun SANYAL (USA) Pierre BEDOSSA (France)
2-How to manage patients with NASH?
Chairs: Lawrence SERFATY (France) Stefano BELLENTANI (Italy)
3-Long term benefits and side effects of NUC therapy for HBV.
Chairs: Rafael ESTEBAN (Spain) Pietro LAMPERTICO (Italy)
4-New therapeutic strategies in HBV patients
Chairs: Massimo LEVRERO (France)
Download
Thomas BERG (Germany)
5-Liver transplantation issues in 2018
Chairs: Didier SAMUEL (France) Pierre-Alain CLAVIEN (Switzerland)
6-Diagnostic et prise en charge d’un patient avec NASH (French speaking lunch workshop)
Chairs: Daniel DHUMEAUX (France) Jean-François David CADRANEL (France)
-
14:30 - 15:30
END STAGE LIVER DISEASE AND TRANSPLANTATION
Chairs :
Richard MOREAU (France) François DURAND (France)
-
14:30 - 14:45
Infections complicating cirrhosis
- Paolo ANGELI (Italy)
Download
- 14:45 - 15:00 Allocation of liver grafts throughout the world. What is the best system? - Pierre-Alain CLAVIEN (Switzerland)
-
15:00 - 15:15
How to improve the long-term outcome after liver transplantation
- François DURAND (France)
Download
- 15:15 - 15:30 Round table discussion
-
15:30 - 15:50
State of the art LECTURE
Chairman:
Patrick MARCELLIN (France)
-
Vascular liver diseases: Current management and new concepts
- Dominique VALLA (France)
Download
-
15:50 - 16:50
HCC SESSION
Chairs :
Massimo COLOMBO (Italy) Didier SAMUEL (France)
-
15:50 - 16:05
Updated 2018 EASL CPGs
- Peter GALLE (Germany)
Download
-
16:05 - 16:20
The impact of DAAs on HCC occurence
- Didier SAMUEL (France)
Download
-
16:20 - 16:35
New approaches in therapy
- Bruno SANGRO (Spain)
Download
- 16:35 - 16:50 Round table discussion
- 16:50 - 17:00 Take home messages - Michael FRIED (USA)
- 17:00 - 17:15 Conclusion - Patrick MARCELLIN (France)
- 17:30 Ajournement